Fishman Jay A LTD Pmv Pharmaceuticals, Inc. Transaction History

Fishman Jay A LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$1.51 - $2.21 $100,226 - $146,688	66,375 Added 1831.03%	70,000 $113,000
Q2 2024 Jul 31, 2024	SELL	$1.51 - $2.21 $115,326 - $168,788	-76,375 Reduced 95.47%	3,625 $5,000
Q1 2024 Apr 23, 2024	BUY	$1.51 - $3.12 $75,500 - $156,000	50,000 Added 166.67%	80,000 $136,000
Q4 2023 Jan 24, 2024	BUY	$1.23 - $6.6 $36,900 - $198,000	30,000 New	30,000 $93,000
Q2 2023 Aug 15, 2023	BUY	$3.94 - $6.27 $118,200 - $188,100	30,000 New	30,000 $187,000
Q1 2023 May 09, 2023	BUY	$4.77 - $9.16 $23,849 - $45,800	5,000 Added 25.0%	25,000 $119,000
Q4 2022 Feb 13, 2023	BUY	$8.17 - $12.95 $81,700 - $129,500	10,000 Added 100.0%	20,000 $174,000
Q3 2022 Oct 26, 2022	BUY	$11.4 - $17.18 $114,000 - $171,800	10,000 New	10,000 $119,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

Stay updated on Fishman Jay A LTD with notifications on news.